| Study | Population | Intervention | Comparison | Comments |
|---|---|---|---|---|
| Inpatient setting (K=2, N=119) | ||||
|
Wang 2014a RCT China |
Inpatient N=77 Baseline severity: More severe Mean age (years): NR Sex (% female): 72 Ethnicity (% BME): NR | Traditional acupuncture (30 sessions) + any SSRI (dose NR) | Any SSRI (dose NR) |
Treatment duration (weeks): 6 Outcome (for inpatient versus outpatient subgroup analysis):
|
|
Zhang 2007a RCT China |
Inpatient N=42 Baseline severity: More severe Mean age (years): 36.8 Sex (% female): 50 Ethnicity (% BME): NR | Electroacupunctu re (36x 30-min sessions) + paroxetine 10-40mg/day | Paroxetine 10-40mg/day |
Treatment duration (weeks): 6 Outcome (for inpatient versus outpatient subgroup analysis):
|
| Outpatient setting (K=2, N=637) | ||||
|
Qu 2013 RCT China |
Outpatient N=160 Baseline severity: More severe Mean age (years): 33.3 Sex (% female): 59 Ethnicity (% BME): NR | Traditional acupuncture or electroacupuncture (18 sessions) + paroxetine 20-40mg/day | Paroxetine 20-40mg/day |
Treatment duration (weeks): 6 Outcome (for inpatient versus outpatient subgroup analysis):
|
|
Zhao 2019a RCT China |
Outpatient N=477 Baseline severity: More severe Mean age (years): 41.5 Sex (% female): 65 Ethnicity (% BME): NR | Traditional acupuncture or electroacupuncture (18x 30-min sessions) + any SSRI (most commonly paroxetine 20mg/day) | Any SSRI (most commonly paroxetine 20mg/day) |
Treatment duration (weeks): 6 Outcome (for inpatient versus outpatient subgroup analysis):
|
BME: black, minority, ethnic; mg: milligrams; N: number of participants; NR: not reported; RCT: randomised controlled trial; SSRI: selective serotonin reuptake inhibitor.
From: Service delivery Models and settings for delivery of services
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.